Literature DB >> 4588701

Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study.

D G Maki, C G Hennekens, C W Phillips, W V Shaw, J V Bennett.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4588701     DOI: 10.1093/infdis/128.5.579

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  35 in total

1.  Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens.

Authors:  A Molla; T Akaike; H Maeda
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Cloning and sequence of the gene encoding the major structural component of mannose-resistant fimbriae of Serratia marcescens.

Authors:  Y Mizunoe; Y Nakabeppu; M Sekiguchi; S Kawabata; T Moriya; K Amako
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

3.  Degradation of protease inhibitors, immunoglobulins, and other serum proteins by Serratia protease and its toxicity to fibroblast in culture.

Authors:  A Molla; K Matsumoto; I Oyamada; T Katsuki; H Maeda
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Role of cell-bound hemolysin as a pathogenicity factor for Serratia infections.

Authors:  W König; Y Faltin; J Scheffer; H Schöffler; V Braun
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Outbreak of nosocomial urinary tract infections caused by Serratia marcescens.

Authors:  T Okuda; N Endo; Y Osada; H Zen-Yoji
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

6.  Resistance plasmid transfer by Serratia marcescens in urine.

Authors:  D R Schaberg; A K Highsmith; I K Wachsmuth
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

7.  Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.

Authors:  I B Ducan; J L Penner
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

8.  Serotyping in epidemiological tracing of nosocomially acquired Proteus mirabilis in a geriatric ward.

Authors:  P Larsson; H E Andersson; B Norlén
Journal:  Infection       Date:  1978       Impact factor: 3.553

9.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

10.  Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit.

Authors:  Baek-Nam Kim; Soon-Im Choi; Nam-Hee Ryoo
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.